An employee at BioNTech, Rhineland-Palatinate, Mainz, on 27 July 2023.

Source: https://fortune.com/2023/08/08/thomas-andreas-struengmann-billionaire-twins-germany-health-medicine-vaccines/

Baillie Gifford & Co. raised its stake in shares of BioNTech by 6.5% in the fourth quarter.

Source: https://www.etfdailynews.com/2023/06/10/american-century-companies-inc-has-11-37-million-stock-holdings-in-biontech-se-nasdaqbntx/

Bank of America raised BioNTech from a “neutral” rating to a “buy” rating and set a $239.00 price target for the company in a research report on Thursday, December 15th.

Source: https://www.americanbankingnews.com/2023/01/13/biontech-nasdaqbntx-shares-down-3-8.html

Berenberg Bank set a $260.00 target price on BioNTech in a research report on Tuesday, March 28th.

Source: https://www.etfdailynews.com/2023/05/19/cambridge-investment-research-advisors-inc-reduces-holdings-in-biontech-se-nasdaqbntx/

BioNTech Chief Executive Officer ("CEO") Ugur Sahin said on BioNTech's third-quarter 2023 Given.

Source: https://seekingalpha.com/article/4659373-biontech-covid-19-success-paves-way-for-strong-drug-pipeline?source=feed_all_articles

BioNTech initiates clinical trial of mRNA-based malaria vaccine…

Source: https://cyprus-mail.com/2023/01/01/2023-one-thing-is-for-sure-france-and-germany-will-not-go-to-war/

"Combination vaccines have the potential to become a mainstay of routine vaccination against respiratory diseases, especially for the vaccination of populations who have a higher risk of severe illness," said Ugur Sahin, CEO and co-founder of BioNTech.

Source: https://www.ndtv.com/world-news/positive-trial-for-pfizer-biontech-covid-flu-jab-4517538

DekaBank Deutsche Girozentrale decreased its position in shares of BioNTech SE () by 2.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.

Source: https://www.americanbankingnews.com/2023/07/09/dekabank-deutsche-girozentrale-has-29-74-million-stake-in-biontech-se-nasdaqbntx.html

Now, the NHS has launched a groundbreaking partnership with BioNTech to try and fast-track the development of mRNA cancer vaccines over the next seven years.

Source: https://www.theguardian.com/science/2023/jan/22/the-other-big-c-how-the-science-behind-covid-vaccines-might-help-to-fight-cancer

Pfizer earned record revenue in 2021 and 2022, topping $100 billion last year, after developing its vaccine Comirnaty with German partner BioNTech SE and antiviral treatment Paxlovid on its own.

Source: https://northdenvernews.com/pfizer-slashes-revenue-forecast-on-lower-covid-sales-will-cut-costs-2/

Twitter and the German Federal Office for Information Security, the cybersecurity agency that Morschhaeuser said contacted Twitter on behalf of BioNTech, did not respond to a request for comment.

Source: https://theintercept.com/2023/01/16/twitter-covid-vaccine-pharma/